Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03765489
Other study ID # OAIC 847/16
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 18, 2016
Est. completion date June 21, 2018

Study information

Verified date December 2018
Source University of Chile
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to compare the effect of EMS and conventional physical therapy on strength and muscle mass and development in adult patients with severe sepsis and septic shock.


Description:

Septic patients are at high risk of developing intensive care unit acquired weakness (ICUAW). Electrical muscle stimulation (EMS) has become an alternative exercise for critical and non-cooperative patients.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date June 21, 2018
Est. primary completion date June 21, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Subjects admitted to the ICU of the HCUCH in the period between November 2016 to August 2017 and January to June 2018

- Diagnosis of severe sepsis or septic shock

- More than 48 hours in VMI

- With sedation and / or neuromuscular blockade

- Autovalent prior to admission to the ICU

Exclusion Criteria:

- Subjects from other hospitals / clinics or units of the hospital

- Multiple trauma

- Previous neuromuscular pathology

- Pacemaker users

- Pregnant women

- BMI> 35

- Epilepsy

- Those who have refused to sign informed consent

Study Design


Intervention

Device:
electrical muscle stimulation
electrical muscle stimulation: The parameters used in biceps were: 35 Hz, 250 µs and in quadriceps were: 50 Hz, 400 µs. In both, biphasic wave was used, 45 minutes of total work, 5 seconds of contraction and 10 seconds of relaxation and the intensity was adjusted to present a visible contraction
Procedure:
conventional physical therapy
conventional physical therapy according to the adaptation of the "Start to move" protocol of Gosselink et al

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Chile

Outcome

Type Measure Description Time frame Safety issue
Primary intensive care unit acquired weakness Medical research council sum score: Bilateral testing of 6 muscle groups (shoulder abduction, elbow flexion, wrist extension, hip flexion, knee extension, and ankle dorsiflexion). Ranges from 0 (total paralysis) to 60 (normal strength). Score under 48 points indicates intensive care unit acquired weakness at awakening of the subject, an average of 8 days
Secondary muscle strength Medical research council sum score: Bilateral testing of 6 muscle groups (shoulder abduction, elbow flexion, wrist extension, hip flexion, knee extension, and ankle dorsiflexion). Ranges from 0 (total paralysis) to 60 (normal strength). at awakening of the subject, an average of 8 days
Secondary muscle mass ultrasonography at ICU admission of the subjet, at 48 hours post admission and at awakening of the subject, an average of 8 days
Secondary maximum inspiratory pressure maximum inspiratory pressure at awakening of the subject, an average of 8 days
Secondary days of mechanical ventilation number of days wirh mechanical ventilation an average of 11 days
Secondary Number of Participants with weaning failure Number of Participants who presented reintubation 48 hours post extubation day
Secondary days of ICU stay number of days in ICU at ICU discharge, an average of 18 days
Secondary mortality at 28 days mortality at 28 days post ICU admission
Secondary gait ability at hospital discharge presence or not of gait ability at hospital discharge, an averange of 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT03649633 - Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock Phase 1/Phase 2
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Completed NCT05629780 - Temporal Changes of Lactate in CLASSIC Patients N/A
Recruiting NCT04796636 - High-dose Intravenous Vitamin C in Patients With Septic Shock Phase 1
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Recruiting NCT05066256 - LV Diastolic Function vs IVC Diameter Variation as Predictor of Fluid Responsiveness in Shock N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Recruiting NCT02899143 - Short-course Antimicrobial Therapy in Sepsis Phase 2
Recruiting NCT02580240 - Administration of Hydrocortisone for the Treatment of Septic Shock N/A
Recruiting NCT02565251 - Volemic Resuscitation in Sepsis and Septic Shock N/A
Recruiting NCT02676427 - Fluid Responsiveness in Septic Shock Evaluated by Caval Ultrasound Doppler Examination
Not yet recruiting NCT02547467 - TOADS Study: TO Assess Death From Septic Shock. N/A
Completed NCT02638545 - Hemodynamic Effects of Dexmedetomidine in Septic Shock Phase 3
Terminated NCT02335723 - ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber N/A
Completed NCT02306928 - PK Analysis of Piperacillin in Septic Shock Patients N/A
Completed NCT02204852 - Co-administration of Iloprost and Eptifibatide in Septic Shock Patients Phase 2